← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2014-08-21

Drug application

FDA Application #

ANDA202915

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOCETIRIZINE DIHYDROCHLORIDE

Generic name

Levocetirizine Dihydrochloride

Active ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

APOTEX

First approval

2014-08-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown